Is Preoperative Hepatic Arterial Chemoembolization Safe and Effective for Hepatocellular Carcinoma?
Open Access
- 1 July 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 224 (1), 4-9
- https://doi.org/10.1097/00000658-199607000-00002
Abstract
The value of preoperative transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) has not been duly appreciated. The authors assessed the advantages and disadvantages of preoperative TACE by reviewing their experience with the procedure. A total of 140 patients who underwent hepatectomy for HCC were entered into the study (105 received preoperative TACE and 35 did not). The authors investigated the reduction of tumor size and the complications after TACE, as well as the relationship between the interval from TACE to resection and the occurrence of complications. They compared postoperative morbidity and mortality between the TACE and non-TACE groups. They also compared survival and disease-free survival between the two groups, as well as between subgroups, defined by the extent of tumor necrosis achieved with TACE. A distinct reduction of tumor size was observed in approximately half of the TACE group. However, there were 68 appreciable complications of TACE in 56 patients (53.3%), and the interval between TACE and resection was significantly prolonged in the patients with complications. The postoperative morbidity and mortality rates of the TACE group were not different from those of the non-TACE group. Preoperative TACE did not improve the survival or disease-free survival of the whole patient group after hepatectomy. In addition, the survival and disease-free survival rates of the three TACE subgroups were not different from those of the non-TACE group. Preoperative TACE should only be performed to reduce tumor bulk in patients with HCC with borderline resectability. In such patients, increased tumor resectability appears to improve the survival rate. Preoperative TACE does not promote tumor recurrence.Keywords
This publication has 16 references indexed in Scilit:
- Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosisCancer, 1993
- Surgical management of large hepatocellular carcinomas: criteria for curative hepatectomy.1993
- Improved Survival for Hepatocellular Cancer With Combination Surgery and Multimodality TreatmentAnnals of Surgery, 1993
- Postoperative recurrence of hepatocellular carcinoma: Results of transcatheter arterial chemoembolizationCardioVascular and Interventional Radiology, 1993
- Postresection Recurrence of Hepatocellular Carcinoma Treated by Arterial Embolization: Analysis of Prognostic FactorsHepatology, 1992
- Hepatic Resection Is Not Enough For Hepatocellular Carcinoma A Follow-up Study of 92 PatientsJournal of Clinical Gastroenterology, 1992
- Experience with 225 hepatic resections for hepatocellular carcinoma over a 4-year periodThe American Journal of Surgery, 1991
- Transcatheter arterial embolization in unresectable hepatocellular carcinomaCardioVascular and Interventional Radiology, 1990
- Percutaneous ethanol injection therapy of hepatomaCardioVascular and Interventional Radiology, 1990
- Surgery and portal hypertension.1964